Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Qlife Holding AB (publ) was incorporated in 2019 and is based in Gothenburg, Sweden.
Frequently asked questions
What sector does Qlife Holding AB (QLIFE) operate in?
Qlife Holding AB belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Qlife Holding AB (QLIFE) current stock price?
As of the latest data, Qlife Holding AB stock price is SEK 1.84, with a previous close of SEK 1.89. Qlife Holding AB lost -SEK 0.05 in the last trading session, representing a -2.65% loss.
What is Qlife Holding AB (QLIFE) current market capitalization?
Qlife Holding AB market cap is approximately 58.08 million.
What is Qlife Holding AB (QLIFE) Earnings Per Share (EPS)?
The trailing EPS is -SEK 2.35.
What is Qlife Holding AB (QLIFE) EBITDA?
Qlife Holding AB EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -5.50 million.
Does Qlife Holding AB (QLIFE) pay dividends?
No. Qlife Holding AB does not pay a dividend.
What is Qlife Holding AB (QLIFE) beta (volatility) score?
Qlife Holding AB has a beta of 0.601, indicating lower volatility than the overall market.